are there different strengths of tirzepatide Dosage Chart: Complete Dosing Schedule and Guidelines Tirzepatide dose chart: complete dosing

Willow does not prescribe FDA-approved brand-name medications

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist with FDA approvals for two distinct indications: Mounjaro for type 2 diabetes management and Zepbound for chronic weight management in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity

When a lump appears at the injection site Occasionally a small, firm lump forms as tissue heals

The slower gastric emptying caused by Mounjaro may intensify lactose-related symptoms in susceptible individuals

Wegovy can cause more noticeable fatigue than Ozempic in some people because it is given at a higher weekly dose